Phase II Study of Gemcitabine and Cisplatin

Written and Fact-Checked by: Mesothelioma Resource Group
Last updated:
Get A Free Mesothelioma Guide

Trial NCT00003723

Official Title: Phase II Study of Gemcitabine and Cisplatin in Unresectable Malignant Mesothelioma

Rationale: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.

Purpose: Phase II trial to study the effectiveness of gemcitabine plus cisplatin in treating patients with malignant mesothelioma of the pleura that cannot be removed by surgery.

Objectives:

  • Estimate overall survival and confirmed and unconfirmed complete and partial response in patients with unresectable malignant mesothelioma of the pleura treated with gemcitabine plus cisplatin.
  • Evaluate the qualitative and quantitative toxicities of this regimen in this patient population.
  • Eligibility: Male and female mesothelioma patients 18 years of age or older.

Study Design:

  • Primary Purpose: Treatment

Date and Locations:

  • Study Start Date: February 1999

Locations

Reference:
National Institutes of Health

Written by:

Mesothelioma Symptoms was founded by a team of advocates to educate people about this aggressive form of cancer. Mesothelioma affects thousands of people each year. We help give hope to those impacted by mesothelioma.

Get Immediate Help

Call Today. Patient Advocates Are Standing By to Help You.

Being diagnosed with mesothelioma is a very stressful time. Our patient advocates have over 20 years of successfully guiding mesothelioma patients to access treatment and pursue compensation. Let us help you too.

  • Locate top mesothelioma doctors
  • File your mesothelioma claim
  • Access the latest clinical trials

Our patient advocates are ready to help. Call today at (888) 360-2406.

Connect With a Patient Advocate Now
I understand by submitting this form that I am providing my consent to be contacted by Mesothelioma Resource Group and its co-counsel, potentially using automated technology, at the number provided regarding my potential claim/their services. Consent is not required to use their services. Msg frequency varies, and message and data rates may apply. Reply HELP for help or STOP to unsubscribe. SMS Terms of Service. I understand and agree that by submitting this form I agree to the Privacy Policy and Terms of Use and that this form does not create an attorney-client relationship and is not confidential or privileged and may be shared.
Call us at (888) 360-2406 or Talk with us via Live Chat

Mesothelioma Resource Group Logo

Hello, we’re sorry to barge in, but we are available to answer your questions.

Would you like to speak to a live person?